Prediction of Survival With Second-Line Therapy in Biliary Tract Cancer: Actualisation of the AGEO CT2BIL Cohort and European Multicentre Validations

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2019.01.019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2017English

A Nomogram to Predict Overall Survival for Biliary Tract Cancer

Cancer Management and Research
Oncology
2018English

Apatinib Monotherapy as a Second-Line Treatment for Patients With Advanced Biliary Tract Cancer: A Retrospective Single-Center Observational Study

2019English

Impact of Preoperative Body Compositions on Survival Following Resection of Biliary Tract Cancer

Journal of Cachexia, Sarcopenia and Muscle
OrthopedicsSports MedicinePhysiology
2019English

Survival Rates Are Higher in Married Patients With Biliary Tract Cancer: A Population-Based Study

Oncotarget
Oncology
2018English

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression After First-Line Gemcitabine Plus Cisplatin

Cancer Research and Treatment
Cancer ResearchOncology
2019English

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2019English

Systemic Therapy for Biliary Tract Cancers

Oncologist
Cancer ResearchMedicineOncology
2008English

Current Therapy and Future Directions in Biliary Tract Malignancies

Current Treatment Options in Oncology
OncologyPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy